• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用多特征视蛋白恢复患有视网膜变性的小鼠的视力。

Restoring vision in mice with retinal degeneration using multicharacteristic opsin.

作者信息

Wright Weldon, Gajjeraman Sivakumar, Batabyal Subrata, Pradhan Sanjay, Bhattacharya Sulagna, Mahapatra Vasu, Tripathy Ashutosh, Mohanty Samarendra

机构信息

NanoScope Technologies LLC, Bedford, Texas, United States.

出版信息

Neurophotonics. 2017 Oct;4(4):041412. doi: 10.1117/1.NPh.4.4.041412. Epub 2017 Aug 18.

DOI:10.1117/1.NPh.4.4.041412
PMID:28840163
Abstract

Retinal degenerative diseases, such as retinitis pigmentosa (RP) and dry age-related macular degeneration, have led to loss of vision in millions of individuals. Currently, no surgical or medical treatment is available, although optogenetic therapies are in clinical development. We demonstrate vision restoration using multicharacteristics opsin (MCO1) in animal models with degenerated retina. MCO1 is reliably delivered to specific retinal cells via intravitreal injection of adeno-associated virus (vMCO1), leading to significant improvement in visually guided behavior conducted using a radial arm water maze. The time to reach the platform and the number of error arms decreased significantly after delivery of MCO1. Notably, the improvement in visually guided behavior was observed even at light intensity levels orders of magnitude lower than that required for channelrhodopsin-2 opsin. Viability of vMCO1-treated retina is not compromised by chronic light exposure. Safe virus-mediated MCO1 delivery has potential for effective gene therapy of diverse retinal degenerations in patients.

摘要

视网膜退行性疾病,如色素性视网膜炎(RP)和干性年龄相关性黄斑变性,已导致数百万人视力丧失。目前,尚无手术或药物治疗方法,尽管光遗传学疗法正在临床开发中。我们在视网膜退化的动物模型中使用多特征视蛋白(MCO1)证明了视力恢复。通过玻璃体内注射腺相关病毒(vMCO1),MCO1可靠地递送至特定视网膜细胞,从而使使用放射状臂水迷宫进行的视觉引导行为有显著改善。在递送MCO1后,到达平台的时间和错误臂的数量显著减少。值得注意的是,即使在比通道视紫红质-2视蛋白所需光强度低几个数量级的光强度水平下,也观察到视觉引导行为的改善。vMCO1处理的视网膜的活力不会因长期光照而受损。安全的病毒介导的MCO1递送对患者各种视网膜退化进行有效基因治疗具有潜力。

相似文献

1
Restoring vision in mice with retinal degeneration using multicharacteristic opsin.利用多特征视蛋白恢复患有视网膜变性的小鼠的视力。
Neurophotonics. 2017 Oct;4(4):041412. doi: 10.1117/1.NPh.4.4.041412. Epub 2017 Aug 18.
2
Restoring vision in mice with retinal degeneration using multicharacteristic opsin.利用多特征视蛋白恢复患有视网膜变性的小鼠的视力。
Neurophotonics. 2017 Oct;4(4):041505. doi: 10.1117/1.NPh.4.4.041505. Epub 2017 Aug 18.
3
Sensitization of ON-bipolar cells with ambient light activatable multi-characteristic opsin rescues vision in mice.环境光照激活多特征视蛋白使 ON-双极细胞致敏可恢复小鼠视力。
Gene Ther. 2021 Apr;28(3-4):162-176. doi: 10.1038/s41434-020-00200-2. Epub 2020 Oct 22.
4
Optogenetic Therapy for Visual Restoration.光遗传学疗法治疗视觉恢复。
Int J Mol Sci. 2022 Nov 30;23(23):15041. doi: 10.3390/ijms232315041.
5
Optogenetic Stimulation for Restoring Vision to Patients Suffering From Retinal Degenerative Diseases: Current Strategies and Future Directions.光遗传学刺激恢复视网膜退行性疾病患者视力:当前策略和未来方向。
IEEE Trans Biomed Circuits Syst. 2019 Dec;13(6):1792-1807. doi: 10.1109/TBCAS.2019.2951298. Epub 2019 Nov 4.
6
Optogenetic Strategies for Vision Restoration.光遗传学策略在视力恢复中的应用。
Adv Exp Med Biol. 2021;1293:545-555. doi: 10.1007/978-981-15-8763-4_38.
7
Optogenetic Approaches to Restoring Vision.恢复视力的光遗传学方法。
Annu Rev Vis Sci. 2015 Nov 24;1:185-210. doi: 10.1146/annurev-vision-082114-035532.
8
Broadband activation by white-opsin lowers intensity threshold for cellular stimulation.白视蛋白引起的宽带激活降低了细胞刺激的强度阈值。
Sci Rep. 2015 Dec 14;5:17857. doi: 10.1038/srep17857.
9
Optogenetic approaches to therapy for inherited retinal degenerations.光遗传学方法治疗遗传性视网膜退行性疾病。
J Physiol. 2022 Nov;600(21):4623-4632. doi: 10.1113/JP282076. Epub 2022 Aug 17.
10
Optogenetics for retinal disorders.用于视网膜疾病的光遗传学
J Ophthalmic Vis Res. 2014 Jul-Sep;9(3):374-82. doi: 10.4103/2008-322X.143379.

引用本文的文献

1
Marine Derived Strategies Against Neurodegeneration.对抗神经退行性变的海洋衍生策略。
Mar Drugs. 2025 Jul 31;23(8):315. doi: 10.3390/md23080315.
2
Addressing Challenges in Developing Treatments for Inherited Retinal Diseases: Recommendations From the Third Monaciano Symposium.应对遗传性视网膜疾病治疗开发中的挑战:第三届莫纳西亚诺研讨会的建议
Transl Vis Sci Technol. 2025 Aug 1;14(8):37. doi: 10.1167/tvst.14.8.37.
3
Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial.

本文引用的文献

1
Red-shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina.红移通道视紫红质刺激可恢复盲鼠、猕猴视网膜和人类视网膜中的光反应。
EMBO Mol Med. 2016 Nov 2;8(11):1248-1264. doi: 10.15252/emmm.201505699. Print 2016 Nov.
2
Broadband activation by white-opsin lowers intensity threshold for cellular stimulation.白视蛋白引起的宽带激活降低了细胞刺激的强度阈值。
Sci Rep. 2015 Dec 14;5:17857. doi: 10.1038/srep17857.
3
Broad-Band Activatable White-Opsin.宽带可激活白色视蛋白
MCO-010光遗传学疗法在美国斯塔加特病患者中的安全性和有效性(STARLIGHT):一项开放标签的多中心2期试验。
EClinicalMedicine. 2025 Aug 14;87:103430. doi: 10.1016/j.eclinm.2025.103430. eCollection 2025 Sep.
4
A synthetic opsin restores vision in patients with severe retinal degeneration.一种合成视蛋白可恢复严重视网膜变性患者的视力。
Mol Ther. 2025 May 7;33(5):2279-2290. doi: 10.1016/j.ymthe.2025.03.031. Epub 2025 Mar 21.
5
Evolution of Light-Sensitive Proteins in Optogenetic Approaches for Vision Restoration: A Comprehensive Review.用于视力恢复的光遗传学方法中光敏蛋白的演变:全面综述
Biomedicines. 2025 Feb 10;13(2):429. doi: 10.3390/biomedicines13020429.
6
Gene Therapies in Clinical Development to Treat Retinal Disorders.处于临床开发阶段的用于治疗视网膜疾病的基因疗法。
Mol Diagn Ther. 2024 Sep;28(5):575-591. doi: 10.1007/s40291-024-00722-0. Epub 2024 Jul 2.
7
Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration.细胞和亚细胞光学遗传学方法在神经保护和视力恢复中的应用。
Prog Retin Eye Res. 2023 Sep;96:101153. doi: 10.1016/j.preteyeres.2022.101153. Epub 2022 Dec 8.
8
Optogenetic Therapy for Visual Restoration.光遗传学疗法治疗视觉恢复。
Int J Mol Sci. 2022 Nov 30;23(23):15041. doi: 10.3390/ijms232315041.
9
Update on Viral Gene Therapy Clinical Trials for Retinal Diseases.视网膜疾病病毒基因治疗临床试验的最新进展。
Hum Gene Ther. 2022 Sep;33(17-18):865-878. doi: 10.1089/hum.2022.159.
10
Biodistribution of adeno-associated virus type 2 carrying multi-characteristic opsin in dogs following intravitreal injection.经玻璃体内注射携带多特征视蛋白的腺相关病毒 2 型在犬体内的分布。
J Cell Mol Med. 2021 Sep;25(18):8676-8686. doi: 10.1111/jcmm.16823. Epub 2021 Aug 21.
PLoS One. 2015 Sep 11;10(9):e0136958. doi: 10.1371/journal.pone.0136958. eCollection 2015.
4
Independent optical excitation of distinct neural populations.独立光学激发不同的神经群体。
Nat Methods. 2014 Mar;11(3):338-46. doi: 10.1038/nmeth.2836. Epub 2014 Feb 9.
5
ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation.ReaChR:一种红色偏移的通道视紫红质变体,可实现深颅穿透光遗传学激发。
Nat Neurosci. 2013 Oct;16(10):1499-508. doi: 10.1038/nn.3502. Epub 2013 Sep 1.
6
Interim results from the international trial of Second Sight's visual prosthesis.国际第二视觉视觉假体试验的中期结果。
Ophthalmology. 2012 Apr;119(4):779-88. doi: 10.1016/j.ophtha.2011.09.028. Epub 2012 Jan 11.
7
Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness.病毒介导的通道视紫红质-2 安全有效地恢复了多种失明小鼠模型的视觉功能。
Mol Ther. 2011 Jul;19(7):1220-9. doi: 10.1038/mt.2011.69. Epub 2011 Apr 19.
8
Subretinal electronic chips allow blind patients to read letters and combine them to words.视网膜下电子芯片使盲人能够阅读字母并将它们组合成单词。
Proc Biol Sci. 2011 May 22;278(1711):1489-97. doi: 10.1098/rspb.2010.1747. Epub 2010 Nov 3.
9
Optical interrogation of neural circuits in Caenorhabditis elegans.秀丽隐杆线虫神经回路的光学检测
Nat Methods. 2009 Dec;6(12):891-6. doi: 10.1038/nmeth.1397. Epub 2009 Nov 8.
10
CCR3 is a target for age-related macular degeneration diagnosis and therapy.趋化因子受体3是年龄相关性黄斑变性诊断和治疗的一个靶点。
Nature. 2009 Jul 9;460(7252):225-30. doi: 10.1038/nature08151. Epub 2009 Jun 14.